Dvax investor relations
WebMay 8, 2024 · Dynavax Technologies Corporation ( NASDAQ: DVAX) Q1 2024 Earnings Conference Call May 7, 2024 4:30 PM ET Company Participants Nicole Arndt - Senior Manager, Investor Relations Ryan Spencer -... WebNov 6, 2024 · Welcome to the Dynavax third-quarter 2024 financial results and corporate update conference call. Joining me on the call today are Ryan Spencer, chief executive officer; Michael Ostrach, chief...
Dvax investor relations
Did you know?
WebAug 7, 2024 · Dynavax Technologies Corporation (NASDAQ:NASDAQ:DVAX) Q2 2024 Results Conference Call August 7, 2024 4:30 PM ETCompany ParticipantsHeather Rowe - … WebMay 7, 2024 · Welcome to the Dynavax first-quarter 2024 financial results and corporate update conference call. Joining me on the call today are Ryan Spencer, chief executive officer; Kelly MacDonald, chief...
WebApr 10, 2024 · See the latest Dynavax Technologies Corp stock price (NASDAQ:DVAX), related news, valuation, dividends and more to help you make your investing decisions. WebFounded. 1996. Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines …
WebFeb 24, 2024 · Starting with revenue. Total revenue for 2024 was $723 million compared to $439 million for 2024, representing an annual increase of about 64%, which was driven both by HEPLISAV-B as well as CpG ... WebJul 6, 2024 · /PRNewswire/ -- Dynavax Technologies Corporation (Dynavax, Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines... Dynavax and Biological E...
WebAug 5, 2024 · Dynavax Technologies Corporation (NASDAQ:NASDAQ:DVAX) Q2 2024 Results Conference Call August 5, 2024 4:30 PM ETCompany ParticipantsNicole Arndt - Senior Manager, IRRyan Spencer - CEOKelly...
WebFeb 4, 2024 · Information on Dynavax's website at www.dynavax.com is not incorporated by reference in our current periodic reports with the SEC. Contacts: Nicole Arndt, Senior Manager, Investor Relations... high springs bmx trackWebNov 6, 2024 · Nicole Arndt-- Senior Manager, Investor Relations. Ryan Spencer-- Chief Executive Officer. Michael Ostrach-- Chief Financial Officer. More DVAX analysis. All … how many days since dec 20 2021WebFeb 28, 2024 · Dynavax ended 2024 with $546 million in cash, cash equivalents and marketable securities, compared to $165 million at the end of 2024. Dynavax generated … high sprained ankle to heal fasterWebDVAX Stock Price - Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines … high springs animalWebMar 10, 2024 · Investor Relations Dynavax Technologies Corp DVAX Financial Information Morningstar Rating Rating as of Mar 10, 2024 Quote Chart Stock Analysis News Price vs Fair Value ... high springs boat salesWebApr 5, 2024 · Currently, Dynavax Technologies Corp’s price-earnings ratio is 5.1. Dynavax Technologies Corp’s trailing 12-month revenue is $722.7 million with a 40.5% profit margin. Year-over-year quarterly sales growth most recently was -5.4%. Analysts expect adjusted earnings to reach $-0.504 per share for the current fiscal year. how many days since dec 23WebMar 3, 2024 · Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly … how many days since dec 2 2022